The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired Phreesia Inc. (“Phreesia” or the “Company”) (NYSE: PHR) common stock between May 8, 2025 and March 30, 2026, inclusive (the “Class Period”). Phreesia investors have until July 13, 2026 to file a lead plaintiff motion.

What Happened?

On March 30, 2026, after market hours, Phreesia announced significantly lowered revenue growth projections for fiscal 2027, citing a combination of macroeconomic factors including “worsening visibility” and weaker pharmaceutical marketing commitments within its Network Solutions segment.

On this news, Phreesia’s stock price fell $3.03, or 26.6%, to close at $8.38 per share on March 31, 2026, thereby injuring investors.

What Is The Lawsuit About?

The complaint filed in this class action alleges that throughout the Class Period, Defendants created the false impression that they possessed reliable information pertaining to the Company’s long-term growth outlook through expansion of its key revenue platforms and remained confident in its revenue growth projections for fiscal year 2027, while also minimizing risks from slowing growth in its Network Solutions segment. In truth, Phreesia’s portrayal of its pharmaceutical marketing commitments as a durable growth driver of its Network Solutions segment was uncertain thereby putting the 2027 revenue target at risk.